Go to main content

A comprehensive guide to core needle biopsies of the breast / Sandra J. Shin, Yunn-Yi Chen, Paula S. Ginter, editors.

Shin, Sandra J. (Sandra Jean), editor.; Chen, Yunn-Yi, editor.; Ginter, Paula S., editor.
2022
RG493.5.B56
Available Online
Formats
Format
BibTeX
MARCXML
TextMARC
MARC
DublinCore
EndNote
NLM
RefWorks
RIS
Add to Basket
Cite

Linked e-resources

Linked Resource
Online Access
Concurrent users
Unlimited
Authorized users
Authorized users
Document Delivery Supplied
Can lend chapters, not whole ebooks

Details

Title
A comprehensive guide to core needle biopsies of the breast / Sandra J. Shin, Yunn-Yi Chen, Paula S. Ginter, editors.
Edition
Second edition.
ISBN
9783031055324 (electronic bk.)
3031055322 (electronic bk.)
9783031055317
3031055314
DOI
https://doi.org/10.1007/978-3-031-05532-4
Published
Cham : Springer, [2022]
Copyright
©2022
Language
English
Description
1 online resource (xvi, 1,019 pages) : illustrations (chiefly color)
Item Number
10.1007/978-3-031-05532-4 doi
Call Number
RG493.5.B56
Dewey Decimal Classification
618.1/90758
Summary
Breast cancer remains the leading cause of cancer in women, which makes accurate diagnoses on core needle biopsy (CNB) specimens of vital importance in staging and guiding therapy decisions for patients. The first edition of this multi-authored text written by leaders in the field from major academic medical centers provided a comprehensive guide on diagnostic breast pathology in the core biopsy setting. In addition to in-depth coverage of benign and malignant entities encountered in breast core biopsies, the book provided additional resources to improve diagnostic accuracy such as pattern-based approaches to evaluation, mimickers of breast lesions arising in extra-mammary sites, and pitfalls specific to small tissue samples. In recent years, there have been several notable developments in the field of breast pathology including revisions in AJCC breast cancer staging, updated guidelines in the testing and reporting of ER, PR, and HER2, as well as implementation of immunotherapy and companion biomarker testing. In addition, several key updates were included in the most recent edition of the WHO Classification of Breast Tumours (2020). In addition to updates specific to individual breast entities, the second edition provides updates regarding biomarker testing in the primary and metastatic setting, and incorporates newly defined entities and updated definitions of rare tumors in alignment with the WHO Classification of Breast Tumours (2020). Furthermore, this edition addresses the role of CNB in companion biomarker testing for eligibility for immunotherapy in the context of advanced triple-negative breast carcinoma. Written by leaders in the field and edited by expert breast pathologists, The Second Edition of Comprehensive Guide to Core Needle Biopsies of the Breast is the definitive reference on breast core needle biopsies for practicing pathologists, pathology trainees, oncologists and clinicians of patients with breast disease. .
Note
Includes index.
Access Note
Access limited to authorized users.
Source of Description
Description based on print version record.
Added Author
Shin, Sandra J. (Sandra Jean), editor.
Chen, Yunn-Yi, editor.
Ginter, Paula S., editor.
Available in Other Form
Comprehensive guide to core needle biopsies of the breast.
Linked Resources
Online Access
Record Appears in
Online Resources > Ebooks
All Resources
Essential Components of a Successful Breast Core Needle Biopsy Program: Imaging Modalities, Sampling Techniques, Specimen Processing, Radiologic/Pathologic Correlation, and Appropriate Follow-Up
Pattern-Based Evaluation of Breast Core Needle Biopsies
Multiples in Core Biopsy Samples
Inflammatory, Reactive, and Infectious Conditions of the Breast
Adenosis, Sclerosing Lesions, Microglandular Adenosis, and Mucocele-Like Lesions
Papillary Tumors and Epithelial and Myoepithelial tumors (Pleomorphic adenoma, Adenomyoepithelioma, Malignant Adenomyoepithelioma)
Fibroepithelial Lesions
Columnar Cell Lesions
Intraductal Proliferations (UDH, ADH, DCIS)
Invasive Ductal Carcinoma, NST (including microinvasive carcinoma), Tubular Carcinoma, and Cribriform Carcinoma
Triple-Negative/Basal-Like Breast Carcinomas
Less Common Triple-Negative Breast Cancers and Salivary Gland-Type Tumors (Carcinoma with Apocrine differentiation, Metaplastic carcinoma, Adenoid Cystic Carcinoma, Secretory Carcinoma, Acinic Cell Carcinoma, Mucoepidermoid carcinoma, Tall Cell Carcinoma with Reversed Polarity)
Special Histologic Types and Special Morphologic Patterns of Invasive Ductal Carcinoma, NST (Mucinous, Micropapillary, Mucinous Cystadenocarcinoma, Cystic Hypersecretory, Glycogen-Rich Clear Cell, Carcinoma with Osteoclast-Like Giant Cells, Neuroendocrine Neoplasms)
Atypical Lobular Hyperplasia and Lobular Carcinoma In Situ
Invasive Lobular Carcinoma
Benign and Malignant Mesenchymal Tumors
Vascular Lesions of the Breast
Breast Tumors in Adolescents/Children and Males
Lesions of the Nippe
Lymphoid and Hematopoietic Tumors of the Breast
Special Clinical Settings: Tumors Arising in Pregnancy, Pregnancy-Like (Pseudolactational) Proliferations, Breast Carcinoma in the Pre-neoadjuvant Chemotherapy Setting, Recurrent Breast Carcinoma, and Inflammatory Breast Carcinoma
Current Standard Clinical Predictive Markers
Future Role of Molecular Profiling in Small Breast Samples and Personalized Medicine
Metastases to the Breast
Dermatologic Mimickers of Breast Lesions Arising in the Breast Skin, Subcutis, or Axilla.

Browse Subjects

Show more subjects...

Statistics

from
to
Export